Riskpilot← Back to searchSign inGet full accessSunmedic AB
ABActiveOrg 5590535646Hammargatan 11 BManufacture of pharmaceutical preparations · NACE 2120Est. 20165-9 employees
Revenue 2024
SEK 16M
-21% vs 2023
EBITDA margin
13.9%
-58% vs 2023
Equity ratio
54.1%
Financial strength
Net profit 2024
SEK 1,4M
-52% vs 2023
| Revenue | SEK 16M | -21% |
| EBITDA | SEK 2,2M | -58% |
| Net profit | SEK 1,4M | -52% |
| Total assets | SEK 12,8M | -17% |
| Equity | SEK 6,9M | +25% |
| Employees | — | — |
Legal name
Sunmedic AB
Org number
5590535646
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
2 mars 2016
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva specialistläkarverksamhet, personal uthyrning inom sjukvården samt import, export, konstruktion, utveckling och tillverkning, försäljning och distribution beträffande läkemedel och medicintekniska produkter, bedriva förvärv, förädling, uthyrningsverksamhet och försäljning av fastigheter, förvaltning av aktier och värdepapper samt därmed förenlig verksamhet.
Address
Hammargatan 11 B
Email
info@sunmedic.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 339 | 606 | 1 205 | 1 011 | 14 733 | 20 245 | 15 958 |
| Staff expenses | — | — | — | — | — | −2 574 | — | — | — |
| EBITDA | 738 | 33 | −109 | −522 | −40 | −3 087 | 4 401 | 5 293 | 2 220 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −62 | −225 | −355 | −416 | −452 |
| EBIT | 738 | 33 | −109 | −522 | −102 | −3 312 | 4 046 | 4 877 | 1 768 |
| Net financials | — | −1 | −2 | — | −4 | −0 | −32 | −21 | −20 |
| Profit before tax | 558 | 32 | −30 | −422 | −105 | −723 | 3 115 | 3 640 | 1 749 |
| Tax | −123 | −7 | −0 | −0 | −0 | −108 | −553 | −754 | −377 |
| Net profit | 435 | 25 | −30 | −422 | −105 | −831 | 2 562 | 2 886 | 1 372 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 822 | 830 | 424 | 256 | 1 749 | 2 635 | 9 949 | 15 288 | 12 760 |
| Equity | 485 | 510 | 280 | 108 | 108 | 77 | 2 639 | 5 525 | 6 897 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 |
| Short-term debt | 157 | 140 | 45 | 148 | 1 641 | 2 558 | 6 410 | 7 663 | 3 763 |
| Total debt | 157 | 140 | 45 | 148 | 1 641 | 2 558 | 6 410 | 7 663 | 3 763 |
EBITDA margin
13.9%
This company
15.8%
Market median
-12% vs market
20162024
Equity ratio
54.1%
This company
38.2%
Market median
+42% vs market
20162024
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20162024
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20162024
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20162024
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-03-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 | — | — |
UT Audit | Audit | 2024 | — | — |
MJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
PM Chief Auditor | Chief Auditor | 2021 | — | — |
MA | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sunmedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Parisa Hallaj Karladani | Deputy Chief Executive Officer | 0 companies |
| Ulf Thomas Appelgren | Audit | 0 companies |
| Mehdi Jafari Ozoomcheloei | Chief Executive Officer | 0 companies |
| Per Magnus Persson | Chief Auditor | 0 companies |
| Mats Anders Gyllenberg | Audit | 0 companies |
| Abbas Hallaj Karladani | Chairman | 0 companies |
| Shamisa Adeli | Board of Directors | 0 companies |
| Leila Teimouri | Deputy Board Member | 0 companies |